TORILL NELSON: Open Payments
NPI 1720032485 · CAMDEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 83 payments from 23 companies in 2025. Trend: 2023 $2,048 · 2024 $1,350 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $277 |
| ABBVIE INC. | 16 | $192 |
| PFIZER INC. | 10 | $184 |
| Insulet Corporation | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Amgen Inc. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Dexcom, Inc. | 3 | $66 |
| Abbott Laboratories | 4 | $62 |
| Lilly USA, LLC | 3 | $52 |
Products named: NURTEC ODT, Ozempic, VRAYLAR, Omnipod, OTEZLA, CAPLYTA, Dexcom G6 Transmitter, FREESTYLE LIBRE 3.
Industry payments across SC — which companies pay providers there.
